The results feed into an effort to identify to monoclonal antibody combinations that would prevent and possibly treat HIV ...

The subcutaneous layer is the deepest skin layer. It protects a person’s body and keeps it warm. This layer also provides insulation and protection for vital tissues such as muscles, bones ...

Higher intakes of diet beverages and/or saccharin are associated with an increased risk of developing diabetes over the long ...

New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via an investigational on-body injector shortened treatment time to minutes with similar efficacy and safety ...

IntegriMedical has introduced a needle-free injection system (N-FIS) that eliminates the need for any prick or piercing, ...

ASCO: new Sarclisa data support subcutaneous administration with on-body injector New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via an investigational ...

An oncology nurse shares advice for avoiding exhaustion and soreness when administering subcutaneous injections.

Merck secures U.S. Patent Office backing in its legal battle with Halozyme over Keytruda's injectable version. Read more here ...

Bristol Myers Squibb Canada (BMS) today announced that Health Canada has approved OPDIVO® SC (nivolumab for subcutaneous injection) across all currently authorized solid tumour indications in ...

The European Commission (EC) has approved a new Opdivo (nivolumab) formulation associated with a new route of administration ...

The subcutaneous formulation of nivolumab, co-formulated with rHuPH20, is approved for multiple solid tumor indications in the EU and Canada. The CheckMate-67T trial showed subcutaneous nivolumab's ...